Publication: Disruptions in Tiopronin Therapy: Impacts on Clinical Outcomes of Pediatric Cystinuria Patients During the COVID-19 Pandemic
| dc.authorscopusid | 57299475600 | |
| dc.authorscopusid | 54400253600 | |
| dc.authorscopusid | 55340326300 | |
| dc.authorscopusid | 55419673200 | |
| dc.authorscopusid | 55654732900 | |
| dc.authorscopusid | 7003365098 | |
| dc.authorscopusid | 11240177700 | |
| dc.authorwosid | Sarikaya, Saban/Aab-2042-2021 | |
| dc.authorwosid | Nalçacıoğlu, Hülya/L-1713-2016 | |
| dc.contributor.author | Onal, Huelya Gozde | |
| dc.contributor.author | Nalcacioglu, Huelya | |
| dc.contributor.author | Karali, Demet Tekcan | |
| dc.contributor.author | Bilgici, Meltem Necibe Ceyhan | |
| dc.contributor.author | Aydog, Ozlem | |
| dc.contributor.author | Ozkaya, Ozan | |
| dc.contributor.author | Sarikaya, Saban | |
| dc.contributor.authorID | Önal, Hülya Gözde/0000-0002-3691-0933 | |
| dc.contributor.authorID | Ozden, Ender/0000-0003-3196-4024 | |
| dc.date.accessioned | 2025-12-11T01:20:16Z | |
| dc.date.issued | 2025 | |
| dc.department | Ondokuz Mayıs Üniversitesi | en_US |
| dc.department-temp | [Onal, Huelya Gozde; Nalcacioglu, Huelya; Karali, Demet Tekcan] Ondokuz Mayis Univ, Dept Pediat Nephrol, Samsun, Turkiye; [Bilgici, Meltem Necibe Ceyhan] Ondokuz Mayis Univ, Dept Radiol, Samsun, Turkiye; [Aydog, Ozlem] Med Pk Bahcelievler Hosp, Pediat Nephrol Clin, Istanbul, Turkiye; [Ozkaya, Ozan] Istinye Univ, Liv Bahcesehir Hosp, Dept Pediat Nephrol, Istanbul, Turkiye; [Ozden, Ender; Sarikaya, Saban] Ondokuz Mayis Univ, Dept Urol, Samsun, Turkiye; [Onal, Huelya Gozde] Samsun Training & Res Hosp, Dept Pediat Nephrol, Samsun, Turkiye | en_US |
| dc.description | Önal, Hülya Gözde/0000-0002-3691-0933; Ozden, Ender/0000-0003-3196-4024; | en_US |
| dc.description.woscitationindex | Science Citation Index Expanded | |
| dc.identifier.doi | 10.1007/s00240-025-01802-4 | |
| dc.identifier.issn | 2194-7228 | |
| dc.identifier.issn | 2194-7236 | |
| dc.identifier.issue | 1 | en_US |
| dc.identifier.pmid | 40560459 | |
| dc.identifier.scopus | 2-s2.0-105009767601 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.uri | https://doi.org/10.1007/s00240-025-01802-4 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/43002 | |
| dc.identifier.volume | 53 | en_US |
| dc.identifier.wos | WOS:001517046000001 | |
| dc.identifier.wosquality | Q2 | |
| dc.language.iso | en | en_US |
| dc.publisher | Springer | en_US |
| dc.relation.ispartof | Urolithiasis | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.title | Disruptions in Tiopronin Therapy: Impacts on Clinical Outcomes of Pediatric Cystinuria Patients During the COVID-19 Pandemic | en_US |
| dc.type | Correction | en_US |
| dspace.entity.type | Publication |
